{
  "ptid_time": "036_S_4562_2012-04-12",
  "img_path": "/data/qiuhui/data/adni/images/036_S_4562/2012-04-12/t1.nii.gz",
  "img_finding": "",
  "text_data": "Age is 63.6 years. Gender is Male. Education: 18 years. Handedness: Right. Race: White. Medical history: Psychiatric; Cardiovascular; Musculoskeletal; Endocrine-Metabolic; Renal-Genitourinary; Allergies or Drug Sensitivities. MMSE: 24.0. MoCA: 22.0. Logical Memory: 0.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.32 SUVR (moderate elevated); Amyloid beta: 312.40 pg/mL (moderate reduced); Total tau: 231.60 pg/mL (normal ); Phosphorylated tau: 23.97 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "Reasoning: The patient shows moderate reduction in Aβ and moderate elevation in AV45, suggesting amyloid pathology, which is consistent with Alzheimer's disease. The MMSE (24) and MoCA (22) scores indicate mild cognitive impairment, but not severe enough for a dementia diagnosis.  \nDiagnosis: MCI (likely due to Alzheimer's pathology)  \nConfidence: Medium (clinical scores and biomarkers align with MCI, but lack of severe cognitive decline rules out dementia)",
  "timestamp": "2025-07-26T06:15:44.446355"
}